Depression causing hair loss


SAMHSA’s National Helpline | SAMHSA

Solr Mobile Search

Share Buttons

Your browser is not supported

Switch to Chrome, Edge, Firefox or Safari

Main page content

  • SAMHSA’s National Helpline is a free, confidential, 24/7, 365-day-a-year treatment referral and information service (in English and Spanish) for individuals and families facing mental and/or substance use disorders.

    Also visit the online treatment locator.

SAMHSA’s National Helpline, 1-800-662-HELP (4357) (also known as the Treatment Referral Routing Service), or TTY: 1-800-487-4889 is a confidential, free, 24-hour-a-day, 365-day-a-year, information service, in English and Spanish, for individuals and family members facing mental and/or substance use disorders. This service provides referrals to local treatment facilities, support groups, and community-based organizations.

Also visit the online treatment locator, or send your zip code via text message: 435748 (HELP4U) to find help near you. Read more about the HELP4U text messaging service.

The service is open 24/7, 365 days a year.

English and Spanish are available if you select the option to speak with a national representative. Currently, the 435748 (HELP4U) text messaging service is only available in English.

In 2020, the Helpline received 833,598 calls. This is a 27 percent increase from 2019, when the Helpline received a total of 656,953 calls for the year.

The referral service is free of charge. If you have no insurance or are underinsured, we will refer you to your state office, which is responsible for state-funded treatment programs. In addition, we can often refer you to facilities that charge on a sliding fee scale or accept Medicare or Medicaid. If you have health insurance, you are encouraged to contact your insurer for a list of participating health care providers and facilities.

The service is confidential. We will not ask you for any personal information. We may ask for your zip code or other pertinent geographic information in order to track calls being routed to other offices or to accurately identify the local resources appropriate to your needs.

No, we do not provide counseling. Trained information specialists answer calls, transfer callers to state services or other appropriate intake centers in their states, and connect them with local assistance and support.

  • Suggested Resources

    What Is Substance Abuse Treatment? A Booklet for Families
    Created for family members of people with alcohol abuse or drug abuse problems. Answers questions about substance abuse, its symptoms, different types of treatment, and recovery. Addresses concerns of children of parents with substance use/abuse problems.

    It's Not Your Fault (NACoA) (PDF | 12 KB)
    Assures teens with parents who abuse alcohol or drugs that, "It's not your fault!" and that they are not alone. Encourages teens to seek emotional support from other adults, school counselors, and youth support groups such as Alateen, and provides a resource list.

    After an Attempt: A Guide for Taking Care of Your Family Member After Treatment in the Emergency Department
    Aids family members in coping with the aftermath of a relative's suicide attempt. Describes the emergency department treatment process, lists questions to ask about follow-up treatment, and describes how to reduce risk and ensure safety at home.

    Family Therapy Can Help: For People in Recovery From Mental Illness or Addiction
    Explores the role of family therapy in recovery from mental illness or substance abuse. Explains how family therapy sessions are run and who conducts them, describes a typical session, and provides information on its effectiveness in recovery.

    For additional resources, please visit the SAMHSA Store.

Last Updated

Last Updated: 08/30/2022

Alcohol, Tobacco, and Other Drugs

Solr Mobile Search

Share Buttons

Your browser is not supported

Switch to Chrome, Edge, Firefox or Safari

Misusing alcohol, tobacco, and other drugs can have both immediate and long-term health effects.

The misuse and abuse of alcohol, tobacco, illicit drugs, and prescription medications affect the health and well-being of millions of Americans. NSDUH estimates allow researchers, clinicians, policymakers, and the general public to better understand and improve the nation’s behavioral health. These reports and detailed tables present estimates from the 2021 National Survey on Drug Use and Health (NSDUH).

Alcohol

Data:

  • Among the 133.1 million current alcohol users aged 12 or older in 2021, 60.0 million people (or 45.1%) were past month binge drinkers. The percentage of people who were past month binge drinkers was highest among young adults aged 18 to 25 (29.2% or 9.8 million people), followed by adults aged 26 or older (22.4% or 49.3 million people), then by adolescents aged 12 to 17 (3.8% or 995,000 people). (2021 NSDUH)
  • Among people aged 12 to 20 in 2021, 15.1% (or 5.9 million people) were past month alcohol users. Estimates of binge alcohol use and heavy alcohol use in the past month among underage people were 8.3% (or 3.2 million people) and 1.6% (or 613,000 people), respectively. (2021 NSDUH)
  • In 2020, 50.0% of people aged 12 or older (or 138.5 million people) used alcohol in the past month (i.e., current alcohol users) (2020 NSDUH)
  • Among the 138.5 million people who were current alcohol users, 61.6 million people (or 44. 4%) were classified as binge drinkers and 17.7 million people (28.8% of current binge drinkers and 12.8% of current alcohol users) were classified as heavy drinkers (2020 NSDUH)
  • The percentage of people who were past month binge alcohol users was highest among young adults aged 18 to 25 (31.4%) compared with 22.9% of adults aged 26 or older and 4.1% of adolescents aged 12 to 17 (2020 NSDUH)
  • Excessive alcohol use can increase a person’s risk of stroke, liver cirrhosis, alcoholic hepatitis, cancer, and other serious health conditions
  • Excessive alcohol use can also lead to risk-taking behavior, including driving while impaired. The Centers for Disease Control and Prevention reports that 29 people in the United States die in motor vehicle crashes that involve an alcohol-impaired driver daily

Programs/Initiatives:

  • STOP Underage Drinking interagency portal - Interagency Coordinating Committee on the Prevention of Underage Drinking
  • Interagency Coordinating Committee on the Prevention of Underage Drinking
  • Talk. They Hear You.
  • Underage Drinking: Myths vs. Facts
  • Talking with your College-Bound Young Adult About Alcohol

Relevant links:

  • National Association of State Alcohol and Drug Abuse Directors
  • Department of Transportation Office of Drug & Alcohol Policy & Compliance
  • Alcohol Policy Information Systems Database (APIS)
  • National Institute on Alcohol Abuse and Alcoholism

Tobacco

Data:

  • In 2020, 20.7% of people aged 12 or older (or 57.3 million people) used nicotine products (i.e., used tobacco products or vaped nicotine) in the past month (2020 NSDUH)
  • Among past month users of nicotine products, nearly two thirds of adolescents aged 12 to 17 (63.1%) vaped nicotine but did not use tobacco products. In contrast, 88.9% of past month nicotine product users aged 26 or older used only tobacco products (2020 NSDUH)
  • Tobacco use is the leading cause of preventable death, often leading to lung cancer, respiratory disorders, heart disease, stroke, and other serious illnesses. The CDC reports that cigarette smoking causes more than 480,000 deaths each year in the United States
  • The CDC’s Office on Smoking and Health reports that more than 16 million Americans are living with a disease caused by smoking cigarettes

Electronic cigarette (e-cigarette) use data:

  • In 2021, 13.2 million people aged 12 or older (or 4.7%) used an e-cigarette or other vaping device to vape nicotine in the past month. The percentage of people who vaped nicotine was highest among young adults aged 18 to 25 (14.1% or 4.7 million people), followed by adolescents aged 12 to 17 (5.2% or 1.4 million people), then by adults aged 26 or older (3.2% or 7.1 million people).
  • Among people aged 12 to 20 in 2021, 11.0% (or 4.3 million people) used tobacco products or used an e-cigarette or other vaping device to vape nicotine in the past month. Among people in this age group, 8.1% (or 3.1 million people) vaped nicotine, 5.4% (or 2.1 million people) used tobacco products, and 3. 4% (or 1.3 million people) smoked cigarettes in the past month. (2021 NSDUH)
  • Data from the Centers for Disease Control and Prevention’s 2020 National Youth Tobacco Survey. Among both middle and high school students, current use of e-cigarettes declined from 2019 to 2020, reversing previous trends and returning current e-cigarette use to levels similar to those observed in 2018
  • E-cigarettes are not safe for youth, young adults, or pregnant women, especially because they contain nicotine and other chemicals

Resources:

  • Tips for Teens: Tobacco
  • Tips for Teens: E-cigarettes
  • Implementing Tobacco Cessation Programs in Substance Use Disorder Treatment Settings
  • Synar Amendment Program

Links:

  • Truth Initiative
  • FDA Center for Tobacco Products
  • CDC Office on Smoking and Health
  • National Institute on Drug Abuse: Tobacco, Nicotine, and E-Cigarettes
  • National Institute on Drug Abuse: E-Cigarettes

Opioids

Data:

  • Among people aged 12 or older in 2021, 3. 3% (or 9.2 million people) misused opioids (heroin or prescription pain relievers) in the past year. Among the 9.2 million people who misused opioids in the past year, 8.7 million people misused prescription pain relievers compared with 1.1 million people who used heroin. These numbers include 574,000 people who both misused prescription pain relievers and used heroin in the past year. (2021 NSDUH)
  • Among people aged 12 or older in 2020, 3.4% (or 9.5 million people) misused opioids in the past year. Among the 9.5 million people who misused opioids in the past year, 9.3 million people misused prescription pain relievers and 902,000 people used heroin (2020 NSDUH)
  • According to the Centers for Disease Control and Prevention’s Understanding the Epidemic, an average of 128 Americans die every day from an opioid overdose

Resources:

  • Medications for Substance Use Disorders
  • Opioid Overdose Prevention Toolkit
  • TIP 63: Medications for Opioid Use Disorder
  • Use of Medication-Assisted Treatment for Opioid Use Disorder in Criminal Justice Settings
  • Opioid Use Disorder and Pregnancy
  • Clinical Guidance for Treating Pregnant and Parenting Women With Opioid Use Disorder and Their Infants
  • The Facts about Buprenorphine for Treatment of Opioid Addiction
  • Pregnancy Planning for Women Being Treated for Opioid Use Disorder
  • Tips for Teens: Opioids
  • Rural Opioid Technical Assistance Grants
  • Tribal Opioid Response Grants
  • Provider’s Clinical Support System - Medication Assisted Treatment Grant Program

Links:

  • National Institute on Drug Abuse: Opioids
  • National Institute on Drug Abuse: Heroin
  • HHS Prevent Opioid Abuse
  • Community Anti-Drug Coalitions of America
  • Addiction Technology Transfer Center (ATTC) Network
  • Prevention Technology Transfer Center (PTTC) Network

Marijuana

Data:

  • In 2021, marijuana was the most commonly used illicit drug, with 18. 7% of people aged 12 or older (or 52.5 million people) using it in the past year. The percentage was highest among young adults aged 18 to 25 (35.4% or 11.8 million people), followed by adults aged 26 or older (17.2% or 37.9 million people), then by adolescents aged 12 to 17 (10.5% or 2.7 million people).
  • The percentage of people who used marijuana in the past year was highest among young adults aged 18 to 25 (34.5%) compared with 16.3% of adults aged 26 or older and 10.1% of adolescents aged 12 to 17 (2020 NSDUH)
  • Marijuana can impair judgment and distort perception in the short term and can lead to memory impairment in the long term
  • Marijuana can have significant health effects on youth and pregnant women.

Resources:

  • Know the Risks of Marijuana
  • Marijuana and Pregnancy
  • Tips for Teens: Marijuana

Relevant links:

  • National Institute on Drug Abuse: Marijuana
  • Addiction Technology Transfer Centers on Marijuana
  • CDC Marijuana and Public Health

Emerging Trends in Substance Misuse:

  • Methamphetamine—In 2019, NSDUH data show that approximately 2 million people used methamphetamine in the past year. Approximately 1 million people had a methamphetamine use disorder, which was higher than the percentage in 2016, but similar to the percentages in 2015 and 2018. The National Institute on Drug Abuse Data shows that overdose death rates involving methamphetamine have quadrupled from 2011 to 2017. Frequent meth use is associated with mood disturbances, hallucinations, and paranoia.
  • Cocaine—In 2019, NSDUH data show an estimated 5.5 million people aged 12 or older were past users of cocaine, including about 778,000 users of crack. The CDC reports that overdose deaths involving have increased by one-third from 2016 to 2017. In the short term, cocaine use can result in increased blood pressure, restlessness, and irritability. In the long term, severe medical complications of cocaine use include heart attacks, seizures, and abdominal pain.
  • Kratom—In 2019, NSDUH data show that about 825,000 people had used Kratom in the past month. Kratom is a tropical plant that grows naturally in Southeast Asia with leaves that can have psychotropic effects by affecting opioid brain receptors. It is currently unregulated and has risk of abuse and dependence. The National Institute on Drug Abuse reports that health effects of Kratom can include nausea, itching, seizures, and hallucinations.

Resources:

  • Tips for Teens: Methamphetamine
  • Tips for Teens: Cocaine
  • National Institute on Drug Abuse

More SAMHSA publications on substance use prevention and treatment.

Last Updated

Last Updated: 03/22/2023

Hair Loss Depression - Dr. Acar

The Cosmedica Team

We are an international team committed to providing the best hair transplant services on the market and to informing and educating people around the world about hair loss and its treatments.

Article contents

A threat called hair loss

Thinning hair , thinning hair and baldness are very common human scalp problems. These states are associated with hair loss , otherwise known as alopecia. Hair loss is a condition in which excessive hair loss occurs. Hair loss can be observed in men and women, as well as in representatives of different age groups.

For many years, hair loss experts have associated this threat with hormonal problems , symptoms of old age or other physical illnesses. However, there is new evidence that mental health problems can not only cause hair loss, but also be the result of people losing their hair.

Cosmedica - Dr. Acar , a leading hair clinic, is committed to helping people overcome the symptoms of hair loss and factors such as depression that lead to hair loss . Here are important details about how depression causes hair loss and treatments to follow when treating depression from hair loss.

Common types of hair loss in men and women

Hair loss can have different effects on individuals. This is because different types of hair loss can affect different people. These types of hair loss can be either permanent or temporary.

In general, The American Academy of Dermatology recognizes the following most common types of hair loss.

Alopecia areata: This type of hair loss is most common in young people. Alopecia areata usually causes people with this condition to lose their hair in clumps.

Androgenetic alopecia: This type of hair loss is also called male pattern baldness. This condition causes the hair to fall out in the middle in an "M" shape.

Telogen effluvium: Telogen effluvium occurs mainly due to stress and is characterized by large amounts of hair loss. Hair loss in this disease begins at the resting stage of the hair growth cycle.

Trichotillomania: this condition is known as hair-pulling disorder and usually results in a constant and irresistible impulse to pull hair from various parts of the body.

Trichorrhexis nodosa: Unlike other conditions that cause hair to fall off the scalp, trichorrhexis nodosum simply breaks off at weak points.

Relationship between depression and hair loss

Patients with mental illnesses always experience far-reaching consequences from the conditions they suffer from. But more recently, hair loss has been linked to suffering from anxiety and depression. Although there are no direct studies that prove that depression causes hair loss, there are several types of studies that show how depression can cause the conditions that lead to hair loss.

One such condition is stress . With increased levels of stress, the likelihood of thinning hair and hair loss can increase. Hair loss can also be the result of stress associated with childbirth or depression caused by unwanted life events or problems such as death, ill health, or problems at work.

Chronic use of birth control pills can also lead to some level of depression. This, in turn, leads to hormonal imbalance - a strong factor responsible for hair loss. Similarly, people who use antidepressants usually experience hair loss as a side effect of taking them.

Hair loss depression treatment

If you are suffering from depression associated with hair loss it is important to take steps to restore healthy hair. One of the best methods is to take care of the health issues that usually lead to depression.

If the hair does not grow back, a hair transplant can be considered. Hair transplantation involves taking hair from a donor area of ​​the body and transplanting it to areas of the scalp where the hair has fallen out.

Hair transplant is a common procedure at Cosmedica and is recommended as a permanent solution to hair loss, especially caused by depression or hereditary factors.

Final Thoughts on Depression in Hair Loss

Although there are several drug treatments for hair loss depression , not all forms of treatment are appropriate due to side effects. That's why you need a specialist to help you get through recovery. Fortunately, Cosmedica does just that. Contact us today to access high quality treatments that will improve your health growth.

Do you have any questions?

If you have any questions about hair transplant in Turkey , Dr. Levent Acar and his team will be happy to help you. Get a free, no-obligation hair consultation today.

Free consultation

sign up

More to learn

Hair loss - why, what to do, how to stop and treat alopecia

Hair loss is a common complaint of patients: hair falls out, what should I do? Alopecia is a clinical problem, especially for general practitioners. The diagnosis is often associated with androgens (a group of steroidal male hormones produced by the testes in men, ovaries in women), unfairly or mistakenly ignoring other causes, including life-threatening patients, but amenable to therapy.

Contents

  • Alopecia: what is it?
  • Causes of alopecia
    • Telogen secretion
    • Nutrition (natural food sources)
    • Trauma alopecia
    • Endocrine imbalance
    • Medicinal cause
    • Infections
    • Special diseases
    • Malignancy
  • Who is a trichologist and why is his advice valuable?
  • Symptoms of hair loss
  • Pathogenesis of hair loss
  • Classification and stages of hair loss
  • Complications
  • Diagnosis
  • Hair loss: treatment
  • Forecast. Prevention

Alopecia: what is it?

The condition associated with hair loss with consequences for the psychosocial functioning of patients (especially women) is called alopecia. Most patients report loss of self-esteem, negative impact on social life, increased depression. The resulting visceral reactions may include:

  • shame;
  • anger;
  • embarrassment;
  • disgust;
  • vulnerability;
  • grief.

Hair is an important component of personal identity with great cosmetic value. The rate of hair loss per day in a healthy person is up to 100-150 pieces. Increased hair loss leads to anxiety. People suffering from this disorder often feel worse, less social contacts, more mental disorders. The psychological impact of baldness is stronger in women.

This disorder is considered a complex clinical problem for physicians, especially primary care and general practitioners, due to its diverse etiology.

The cause of partial or complete loss of hair in most cases is unknown. Clinicians often attribute the etiology to stress or link it to androgens, ignoring other causes, including life-threatening but treatable ones.

Careful history taking, proper examination methods, and prudent use of laboratory tests are necessary to establish a correct diagnosis. A methodical assessment of this disease can lead to the formulation of a proper hair loss treatment plan.

Causes of alopecia

Why does hair fall out on the head? There are seven main systemic causes of hair loss, ranging from infectious agents to the consumption of unsafe supplements.

Telogen secretion

Telogen secretion is a disorder of hair loss. The acute form worsens the quality of life, and spontaneous recovery occurs after at least three months, more often it takes up to six months. Full recovery takes about 12 months. This diffuse alopecia is a non-scarring alopecia, with an unspecified frequency of manifestation, since most cases are subclinical. Affects < 50% of the scalp, usually occurs about a calendar quarter after the initiating event.

An acute form of telogen secretion is provoked by:

  • psychological stress;
  • fever;
  • medical treatment;
  • change of season;
  • diet;
  • childbirth.

Although this disorder can be corrected by removing the underlying cause, there are multiple triggers. In about 30% of cases they cannot be identified.

The growth of each hair occurs in three stages: an intensive growth phase (anagen), followed by catagen, a regressive state caused by apoptosis (natural cell death). The final stage is telogen, meaning the resting and release phase.

Excessive hair loss occurs when an irritant causes a large number of anagen hairs to stop growing prematurely. As well as entry into the telogen phase, which leads to an increase in the number of telogen hairs on the scalp from 5% to 10%, up to 20% or more.

There are different types of telogen shedding, all of which share the common clinical feature of increased telogen hair loss. What to do if hair falls out on the head?

There are no specific medical treatments for isolating telogen. Recovery time depends on the extent of the initial damage. The main treatment for alopecia should be directed to the pathogen. Some reasons:

  • fever;
  • postpartum;
  • use of oral contraceptives;
  • strict diet;
  • effects of anesthesia during surgery.

Chronic release of telogen lasts more than six months, this differs from acute.

Nutrition (natural food sources)

Nutrition plays a key role in maintaining hairline. It can be harmful in excess or deficiency. Protein in the form of keratin is the main component of hair. Not surprisingly, insufficient protein intake, such as in patients with kwashiorkor or anorexia nervosa, has been associated with baldness. With protein-deficient alopecia, microscopy can show their reduced diameter, atrophic anagen bulbs. There may also be color changes, loss of elasticity of the hair strands, and the texture becomes dry.

Hair loss treatment should focus on adequate protein intake from natural food sources. In an amount of at least 60-80 grams per day, unless contraindicated, for example, as in patients with kidney disease.

Essential fatty acids, such as linoleic, alpha-linoleic, are also key components of cell membranes, lamellar bodies of the stratum corneum. Symptoms of their deficiency include depigmentation, hair loss on the scalp and eyebrows. Too much vitamin A is another well-known cause of hair loss. Due to excessive supplementation, some diseases, such as chronic kidney disease, increase vitamin A levels in patients. The recommended daily dose is 10,000 IU.

Metallic cofactors are a necessary category of nutrition.

Deficiency of zinc can lead to numerous skin conditions including brittle hair, periorbital dermatitis, skin superinfections. The ideal daily zinc intake is 8 mg for women, 11 mg for men and pregnant women. Treatment for zinc deficiency is 25-50 mg in adults, 0.5-1 mg in children.

Selenium is another key metal that has long been associated with hair loss when taken in excess. Studies of acute selenium toxicity revealed alopecia in 72% of those affected. The current recommended intake for selenium is 70 mcg/day for men and 55 mcg/day for women.

Iron is another metal that has been postulated for its association with alopecia, although the link between iron deficiency and baldness is still debated. Many scientists hold the position that the condition of the hair improves with the treatment of iron deficiency, regardless of the absence or presence of anemia. Current literature suggests that an adequate ferritin level is 40 mg/L, although anecdotal studies support a range of 10-70 mg/L.

Nutrition (food supplements) is a loosely regulated but rapidly growing industry with a gigantic annual turnover. Currently, there are more than 85,000 nutritional supplements on the global consumer market, but no more than a thousand are officially tested per year. Most companies are infringing, selling their product containing banned ingredients such as phenolphthalein.

They can have a toxic effect on the hair, causing it to fall out. Arsenic, lead and mercury are the main culprits. Their long-term use can lead to toxicity, subsequent baldness. Other chemical impurities found in various supplements include:

  • acrylamides;
  • ethyl carbamate;
  • melamine;
  • radionuclides;
  • sildenafil;
  • fluoxetine;
  • phenolphthalein;
  • aromatase inhibitor;
  • various anabolic steroids.

The connection between baldness and these substances is well known.

Steroids can disrupt endocrine regulation, causing changes in the regulation of hair growth. A sudden drop in estrogen levels can lead to hair loss. In breast cancer, patients treated with aromatase inhibitors are two and a half times more likely to experience baldness.

For consumers, the harmful substances in these dietary supplements can cause baldness, but the ingredients are not immediately recognizable because they are not listed on the labels.

Trauma alopecia

Traumatic alopecia (traction alopecia) is a common form of hair loss. Caused by forceful hair removal or breaking of hair shafts by pressure, traction, friction, or any other physical injury. Wearing tight hairstyles that injure the hairline:

  • tails;
  • pigtails;
  • bundles;
  • heavy strands;
  • dreadlocks;
  • hair extensions.

Frequent use of curlers or a hair dryer. Heavy use of relaxants or straightening chemicals. Wearing tight hats. Fluctuations in hormone levels. All this contributes to baldness.

Trichotillomania (TT) is the obsessive desire or habit of plucking hairs, consciously or unconsciously. The psychiatric classification includes TT in the category of obsessive-compulsive and related disorders.

Endocrine imbalance

In addition to androgen imbalance, both excess and deficiency of thyroid hormones can lead to baldness. This is a single endocrine anomaly or a manifestation of endocrine pathway disorders, for example, in patients with pituitary insufficiency.

Hypothyroidism increases the percentage of telogen in patients. A third of them may experience baldness. With hypothyroidism, cell division is inhibited in the epidermis, skin appendages. Hair damage is usually irreversible, even with thyroid hormone treatment.

Diffuse alopecia areata also occurs in up to 50% of patients with hyperthyroidism and may manifest outside the scalp, although this mechanism is not well understood.

Medicinal cause

Taking certain medications can also lead to baldness:

  • antihypertensives;
  • antiarrhythmics;
  • statins;
  • antimetabolites;
  • psychotropic agents;
  • anticonvulsants;
  • anticoagulants;
  • antiretrovirals;
  • H2 blockers.

In terms of reported cases, affected patients tended to show improvement after discontinuing medication.

The itching of the head and hair loss returned after repeated use of the same remedy. Treatment involves stopping or changing the causative drug.

Infections

Among bacterial infections, treponema pallidum can cause baldness in 4% of patients during secondary syphilis. The clinical picture can be either diffuse or heterogeneous, or a combination of them. The most common location is on the scalp, although other areas such as the eyebrows and chest may be affected. Syphilitic alopecia can often be confused with focal alopecia. A good diagnostic method of differentiating between them is the detection of eosinophils at the sites of the lesion. Spirochetes can also be found in affected hair follicles on biopsy.

Baldness is associated with several viral agents, including viruses:

  • Epstein-Barr;
  • chickenpox;
  • hepatitis C;
  • HIV;
  • cytomegalovirus.

VZV (Varicella-Zoster Virus) is a common culprit in alopecia due to its prevalence. It causes scarring alopecia.

Special diseases

Metabolic imbalance in patients with liver and kidney failure can cause hair loss: hypervitaminosis A, hyperammonemia and hypoproteinemia. Diagnosis requires the appointment of a metabolic panel, and treatment should be directed to the underlying excess or deficiency.

Rheumatological disorders can also manifest themselves in hair loss. This phenomenon is observed in more than 50% of patients with lupus at some stage in the course of the disease. Alopecia without scarring occurs during outbreaks in acute lupus, may resemble telogen discharge. In patients with discoid lupus erythematosus, lesions become cicatricial, and scalp lesions can lead to more than 50% baldness. The remaining hair fibers may be dry and brittle. Histopathological findings may include epidermal atrophy and lymphocytic infiltration in the follicle area.

Connective tissue diseases, especially dermatomyositis, can cause patchy diffuse alopecia. Treatment directed at the underlying pathology, such as immunosuppressants, is often necessary to prevent further baldness. However, with effective treatment, alopecia is reversible for some time after the start of therapy.

Amyloid deposition in amyloidosis can impair the function of the hair follicles, causing a diffuse or patchy lesion of the hairline. A biopsy is required for a definitive diagnosis.

Cutaneous sarcoidosis occurs in 25% of patients with systemic sarcoidosis, although it may appear in the absence of systemic disease. Scalp sarcoidosis is a rare manifestation of the disease and is initially described as a reddened, scaly, atrophic area of ​​hair loss. Local destruction from sarcoidosis, if left untreated, can lead to scarring of the hair follicles, akin to scarring alopecia.

Malignancy

Both systemic and cutaneous hematological malignancies such as leukemia may be accompanied by hair loss regardless of chemotherapy. The presentation is usually associated with mycosis fungoides, the most common form of cutaneous T-cell lymphoma. The phenomenon is called "mucinous alopecia" to describe alopecia and associated itchy papules or plaques. In fact, up to 30% of patients with alopecia mucinosus have mycosis fungoides. Treatment is directed at the underlying cutaneous T-cell lymphoma, although patients with indolent mycosis fungoides have a good prognosis with no further spread of hair loss.

In conclusion, it should be mentioned that baldness can be of an immune nature, as in cases of alopecia areata and other pathologies. There are many individual clinical conditions, and their combinations can confuse even a doctor, so to find out the true culprit of baldness, you need to contact a trichologist.

Who is a trichologist and why is his advice valuable?

What to do if hair falls out on the head? Along with contacting your therapist, it is useful to contact a doctor of a narrow specialization - a trichologist. Often this is a general practitioner - a therapist who has completed an additional training program, or a dermatologist. But unlike the latter, the trichologist focuses on the patient's hairline. In addition to diagnosis, treatment, he can explain how to strengthen hair from falling out. Develop an individualized care program to encourage their normal growth. Trichology - treatment of hair loss.

Symptoms of hair loss

Early signs of baldness include:

  • thinning, thinning hair;
  • appearance of bald patches;
  • slow hair growth;
  • more hairs remain on comb or pillow after sleep;
  • itching of the scalp, which can have several causes. For example - dandruff (is not sufficient evidence of alopecia), as a concomitant condition.

Pathogenesis of hair loss

The culprits of alopecia are usually:

  • androgens;
  • genetic predisposition;
  • autoimmune responses;
  • chronic inflammation;
  • oxidative stress;
  • internal and external environmental factors;
  • psycho-emotional factor and others.

Until now, there are no effective treatments for baldness that do not cause side effects. Perhaps because the influence and interaction of many factors affecting the immune system and signaling pathways that regulate the biology of hair follicles are underestimated.

If hair loss occurs, the causes may be multifactorial and there may be more similarities than differences in the spectrum of baldness disorders.

Like most multigene, chronic systemic skin diseases, alopecia is the result of an accumulation of many causes: genetic and environmental. Which lead to the ultimate molecular pathophysiology. In turn, leading to dysregulation of signaling pathways, inadequate immune and inflammatory responses.

Chronic inflammation at the follicle level appears to be the cause of various types of hair loss. It has already been proven that even with non-inflammatory alopecia there is a micro-inflammatory and fibrous component.

Numerous immune pathways are involved in the normal physiology of the follicle, as well as in the pathophysiology of alopecia. Within the internal follicular environment, numerous cytokines, growth factors, and transcription factors signal the follicle to enter the anagen or catagen phase. They play an important role in regeneration.

It is known that in the case of microinfection, overproduction of cytokines causes premature catagen, release of ROS, apoptosis (natural cell death), and further spread of inflammation.

To this end, in any therapy developed for the complex treatment of hair loss, it is necessary to take into account not only triggering factors, but also their subsequent signal cascades.

The condition of inflammation and oxidative stress in the environment of the follicles that causes hair loss is facilitated by:

  • ultraviolet;
  • contaminants;
  • toxins;
  • stress;
  • aging;
  • smoking;
  • antigenic effect of bacteria and fungi.

Recent studies have further elucidated the molecular mechanisms underlying the role of psycho-emotional stress in the onset and aggravation of hair loss. Chronic stress can lead to inflammation in the area of ​​the funnel of the follicle, its physiological disorders. Via endocrine and neuroimmune mediators such as corticotropin-releasing hormone, cortisol, all of which have receptors on the follicle.

We need to look for a common thread in all hair diseases - a complex dysregulation of immune, inflammatory and signaling cascades that regulate follicle homeostasis. Therefore, any drug/treatment that targets individual triggers such as androgens may be incomplete. If you do not take into account pleiotropic side effects, as well as the interactions of various signaling molecules. In addition, the pathogenesis of this disease is multifactorial, it requires additional consideration:

  • stress;
  • aging;
  • environment;
  • inflammation and others.

Classification and stages of hair loss

Each hair on the body constantly goes through cycles of growth (anagen), regression (catagen), rest (telogen) and loss (exogen). Baldness is usually due to a problem with the hair cycle or due to inflammation directly affecting the follicle. Dermatologists traditionally divide baldness into categories according to different causes and morphology:

  • inflammatory;
  • non-inflammatory;
  • genetic;
  • acquired;
  • scar;
  • not scarred;
  • androgen-mediated and not.

The main categories of alopecia without scarring are:

Alopecia areata (OA). May affect any part of the body. With the defeat of a large area - total alopecia. If baldness of the whole body occurs - universal. The etiology is not exactly known, but the autoimmune theory of OA seems more plausible.

Isolation of anagen. Alopecia that occurs during the anagen phase of the cell cycle. It is observed in cancer patients who receive chemotherapy.

Androgenetic alopecia. A type of hair loss influenced by hormones and genes.

Isolation of telogen. The result of a shift in the hair growth cycle from the anagen phase to the telogen phase. It can be triggered by hypothyroidism or hyperthyroidism. Other causes: stress, alcohol, drugs, strict diet, poor nutrition.

Shingles. The classic type of herpes zoster (viral nature) causes baldness without scarring, unlike other types such as kerion and favus (fungal nature of diseases).

Traumatic alopecia. Occurs as a result of mechanical, chemical damage to the hairline, the habit of pulling out hairs. Trichotillomania is a type of traumatic alopecia in which the patient constantly pulls out their hairs.

Scarring alopecia is divided into three main types:

Mucinous alopecia. Occurs when mucinous material accumulates in hair follicles and sebaceous glands, causing an inflammatory response that prevents hair growth.

Neoplastic alopecia. Observed with metastatic infiltration of the scalp with malignant cells.

In the inflammatory variety of herpes zoster (favus or kerion), when the fungi cause the formation of an abscess, which can culminate in scarring alopecia.

Complications

Patients with alopecia are at an increased risk of psychosocial complications such as anxiety and depression. People in these states may take psychotropic drugs, exacerbating the condition of baldness. Many of these medications are associated with mild to moderate hair loss. Mood stabilizers such as lithium and valproic acid can cause hair loss of varying severity and duration. Patients taking selective OZR inhibitors also experience baldness. It is important that doctors take these points into account when prescribing therapeutic courses, and also examine patients for the presence of autoimmune and other diseases. One study found that patients with alopecia areata are at an increased risk of developing insulin resistance.

With hair loss, psychosomatics becomes an important reason for the deterioration of the general condition of a person.

Diagnostics

Diagnostic measures begin with the collection of an anamnesis, clarification of the patient's medical history.

Key information for history taking includes the number of hairs that fall out, the duration of the pathology, and their distribution over the scalp and body. Important:

  • patient history;
  • recent changes in diet;
  • social stressors;
  • information about medications taken, and much more.

Clinicians should not be quick to attribute a patient's hair loss to androgen imbalances or stress. There are many equally important alternative causes to be tested.

Depending on the clinical suspicions, clinicians should ask targeted questions related to the seven categories of baldness etiologies, looking for possible causes. For example, almost all chemotherapy drugs cause some degree of baldness. For female patients, a history regarding the menstrual cycle, hormonal drugs is useful in establishing the cause of hair loss in girls associated with hormones.

Diagnosis should go beyond dermatological symptoms, since many systemic diseases and infections can be accompanied by alopecia as one of the manifestations.

Physical examination should be aimed at determining the degree of disease, characteristics of alopecia, inflammation. Initial imaging should focus on the distribution of alopecia, in which the diffuse pattern raises clinical suspicions of a systemic cause.

During examination, the patient should be combed. Baldness can also be quantified with a standardized flush test as part of the initial assessment. This is particularly useful for diagnosing chronic telogen shedding prior to more invasive procedures such as trichogram and biopsy.

A rough examination of the fibers of the hair strands can provide additional clues to the patient's pathology. The terminal hairs are pigmented compared to the fine vellus hairs seen in some patients with Cushing's disease or anorexia nervosa. The texture of the hair fibers, especially if they are dry, brittle, may indicate poor hair nutrition. Examination can also reveal brittle hair disguised as hair loss.

Visualization and palpation of the scalp reveals inflammation, scarring, or erythema, which may signal an underlying infection or malignancy.

Instrumental Diagnostics - Scalp dermoscopy can offer a magnification of 20 to 70 times to better visualize the features.

A shiny, smooth skin surface indicates the absence of active hair follicles. The characteristic color of the skin may indicate the underlying inflammation. An important sign is hair loss outside the scalp. Additional loss of the eyebrows suggests thyroid disease, while hair loss on the torso may be a manifestation of amyloidosis or secondary syphilis.

Laboratory diagnosis may be useful in narrowing differential diagnoses. Performing a trichogram can help calculate the ratio of telogen to anagen, give clues to systemic causes. Hair follicles can be examined to determine their relative proportion among the growth phases. The trichogram allows for microscopic evaluation of the hair shaft and follicle, which can be used to distinguish between mechanical, chemical, genetic, and infectious etiologies.

What tests should be done for hair loss? A complete blood count may reveal acute infections or anemia. Studies of iron content, ferritin levels can reveal impaired iron-binding ability. Chemical analysis may reveal a metabolic imbalance that indicates liver or kidney disease. After interpreting the results of the primary tests, the attending physician will explain why hair loss occurs, what tests to take to clarify the cause of baldness.

Additional tests for hair loss are ordered for each patient depending on the individual history:

  • antinuclear antibody test and erythrocyte sedimentation rate may confirm suspicion of autoimmune disorders;
  • tests for specific nutrient deficiencies and excesses such as zinc, selenium and vitamins;
  • tests for the detection of toxic substances such as lead and arsenic for severe clinical suspicion;
  • advanced endocrine studies and imaging may be useful in identifying underlying androgen imbalances or malignancies;
  • If a doctor wants to evaluate a patient's androgen levels, they will order a prolactin and globulin test.

Scalp biopsy. Its main indication is the differentiation of scarring and non-scarring alopecia. Sometimes a biopsy can help diagnose underlying conditions such as amyloidosis and mucinosis.

A wide range of causes is a diagnostic challenge for doctors, requiring effort and time.

With a systematic approach, doctors can identify the underlying cause of alopecia. In addition to minimizing hair loss and maximizing hair regrowth, patients can further benefit from early diagnosis of systemic diseases:

  • nutrient deficiency;
  • endocrine imbalance;
  • collagen or vascular diseases;
  • malignant neoplasms.

Given the serious psychosocial consequences associated with baldness, prompt resolution of the disease can greatly improve a patient's quality of life. It is easier to achieve a cure with an accurate diagnosis and a clear plan for adequate treatment.

Hair loss: treatment

What to do if the hair on the head falls out a lot? Only an appeal to the doctor will be the right decision. He knows how to treat alopecia. It is desirable that the appeal be timely.

How to treat hair loss? The doctor draws up an individual treatment plan in accordance with the etiology, type of baldness, containing local corticosteroids, immunosuppressive drugs. Androgenetic alopecia is treated with anti-androgen medications, as well as minoxidil spray, but the patient may eventually need a hair transplant.

In alopecia areata, moderately effective corticosteroids, as well as minoxidil spray, in combination with topical immunomodulators such as tacrolimus, may benefit the patient. Antifungal drugs are the mainstay of treatment for head zoster. How to treat hair loss? Strictly comply with medical prescriptions.

To achieve the desired therapeutic result, the following is additionally prescribed:

  • cryotherapy;
  • plasma therapy;
  • photobiotherapy;
  • microcurrent therapy;
  • mesotherapy;
  • polynucleotide biorepair.

In some cases, resort to surgical intervention.

Forecast. Prevention

The prognosis must be determined for each case. If we talk about statistics, then according to studies, about 8.5% of patients with total and universal alopecia have achieved a complete recovery. In many patients (approximately 50% of the total cases), after treatment, there is at least a temporary restoration of partial or complete hair regrowth. The response to treatment is often unpredictable, and healthcare professionals must be aware of the prognosis and its consequences in order to properly counsel patients. To prevent the development of damage to the hairline will help the usual preventive measures: